Epitomee Medical Announces FDA Clearance of its Capsule, Weight Management Device
Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription
Solution for Adults with BMI of 25-40 looking for Alternative Drug Free
Solutions for Their Weight Management Needs alongside diet and exercise.
CAESAREA, Israel, Sept. 17, 2024 /PRNewswire/ -- Epitomee Medical Ltd.
Epitomee® announces the filing of a novel Weight Loss Capsule for FDA clearance
CAESAREA, Israel, March 7, 2024 /PRNewswire/ -- Epitomee® (TASE: EPIT) announced today that onFebruary 27, 2024, it has submitted its Weight Loss Capsule for FDA clearance in theUSA, reaching a significant milestone in the company's journey. The Epitomee® capsule offers an innovative, orally adm...
Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule
CAESAREA, Israel, Jan. 16, 2024 /PRNewswire/ -- Epitomee® announces the successful completion of the RESET pivotal clinical trial, for its weight loss capsule. The randomized placebo controlled, double blind trial, investigated the safety and efficacy of Epitomee® capsule versus the sham capsule ...
